Schellenberg Wittmer advised Boehringer Ingelheim, one of the largest pharmaceutical companies, on the acquisition of Saiba Animal Health AG.
Saiba Animal Health AG is focused on the development of novel therapeutic medicines to address chronic diseases in pets.
Our team consisted of Pascal Hubli (overall lead), Elia Schunck, Olivia Wipf, Mario Schwager and Anna Wöller (Corporate/M&A), Philipp Groz and Alisa Zehner (Intellectual Property), Michael Hess and Ruba Kassem (Employment) as well as Michael Nordin and Tabea Elmer (Taxation).
07.10.2024
26.09.2024
27.08.2024